SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001013762-14-001267
Filing Date
2014-10-31
Accepted
2014-10-31 16:38:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 JEFFREY BACHA SCHEDULE 13 D/A sc13da1014bacha_delmar.htm SC 13D/A 27872
  Complete submission text file 0001013762-14-001267.txt   29205
Mailing Address SUITE 3 1545 WEST 14TH AVENUE VANCOUVER A1 V6J 2J1
Business Address
BACHA JEFFREY (Filed by) CIK: 0001432149 (see all company filings)

Type: SC 13D/A

Mailing Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (604) 629-5989
DelMar Pharmaceuticals, Inc. (Subject) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: SC 13D/A | Act: 34 | File No.: 005-87181 | Film No.: 141186992
SIC: 2834 Pharmaceutical Preparations